Discontinuation of botulinum neurotoxin type-A treatment during COVID-19 pandemic: an Italian survey in post stroke and traumatic brain injury patients living with spasticity

Italian Survey

Efficacy and safety of treatment with Incobotulinum toxin A (botulinum neurotoxin type A free from complexing proteins; NT 201) in post-stroke upper limb spasticity

Journal of Rehabilitation Medicine ◽

10.2340/16501977-0796 ◽

2011 ◽

Vol 43 (6) ◽

pp. 486-492 ◽

Cited By ~ 47

Author(s):

P Kaňovský ◽

J Slawek ◽

Z Denes ◽

T Platz ◽

G Comes ◽

...

Keyword(s):

Upper Limb ◽

Botulinum Neurotoxin ◽

Type A ◽

Efficacy And Safety ◽

Toxin A ◽

Post Stroke ◽

Complexing Proteins ◽

Nt 201 ◽

Limb Spasticity

Poster 364: Consistent Efficacy of Botulinum Neurotoxin Type A: A Meta-Analysis From 7 Multicenter Studies of Upper Limb Spasticity in Post-Stroke Patients

Archives of Physical Medicine and Rehabilitation ◽

10.1016/j.apmr.2008.09.370 ◽

2008 ◽

Vol 89 (11) ◽

pp. e139

Author(s):

Christina M. Marciniak ◽

Susan Abu-Shakra ◽

Frederick Beddingfield ◽

Steven Hua ◽

Tatiana Y. Khariton ◽

...

Keyword(s):

Upper Limb ◽

Botulinum Neurotoxin ◽

Meta Analysis ◽

Type A ◽

Stroke Patients ◽

Multicenter Studies ◽

Post Stroke ◽

Limb Spasticity

Clinically meaningful differences of the Ashworth Scale in patients with chronic post-stroke upper limb spasticity treated with botulinum neurotoxin type A (botox®)

Toxicon ◽

10.1016/j.toxicon.2008.04.076 ◽

2008 ◽

Vol 51 ◽

pp. 25

Author(s):

Charles David ◽

R. Zafonte ◽

M.V. Shah ◽

A.M. VanDenburgh ◽

J. Wagg ◽

...

Keyword(s):

Upper Limb ◽

Botulinum Neurotoxin ◽

Type A ◽

Post Stroke ◽

Limb Spasticity ◽

Ashworth Scale

Faculty Opinions recommendation of In the human urothelium and suburothelium, intradetrusor botulinum neurotoxin type A does not induce apoptosis: preliminary results.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1718956.1228054 ◽

2010 ◽

Author(s):

JLH Ruud Bosch

Keyword(s):

Botulinum Neurotoxin ◽

Type A ◽

Preliminary Results ◽

Faculty Opinions recommendation of Botulinum neurotoxin type A is internalized and translocated from small synaptic vesicles at the neuromuscular junction.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717988167.793477443 ◽

2013 ◽

Author(s):

Patrick McNutt ◽

Ian Gut

Keyword(s):

Neuromuscular Junction ◽

Synaptic Vesicles ◽

Botulinum Neurotoxin ◽

Type A ◽

OnabotulinumtoxinA exhibits greater efficacy compared to purified botulinum neurotoxin type A (BoNT/A-150 kDa) in peripheral pain models

Toxicon ◽

10.1016/j.toxicon.2020.11.490 ◽

2021 ◽

Vol 190 ◽

pp. S70

Author(s):

Sudhakar R. Subramaniam ◽

Greg Nicholson ◽

Brian B. Cai ◽

Amy D. Brideau-Andersen ◽

Ron S. Broide

Keyword(s):

Botulinum Neurotoxin ◽

Type A ◽

Pain Models ◽

Peripheral Pain

Not only gustatory sweating and flushing: Signs and symptoms associated with Frey's syndrome and the role of botulinum neurotoxin type A therapy

Toxicon ◽

10.1016/j.toxicon.2020.11.437 ◽

2021 ◽

Vol 190 ◽

pp. S46-S47

Author(s):

Maria Raffaella Marchese ◽

Giovanni Almadori

Keyword(s):

Botulinum Neurotoxin ◽

Signs And Symptoms ◽

Type A ◽

Frey’S Syndrome ◽

Gustatory Sweating ◽

Frey's Syndrome

Real-world treatment intervals with botulinum neurotoxin type A in poststroke spasticity management—Are different formulations different?

Toxicon ◽

10.1016/j.toxicon.2020.11.475 ◽

2021 ◽

Vol 190 ◽

pp. S63

Author(s):

Susana Rosa ◽

Bruno Guimarães ◽

Joana Martins ◽

José Luís Mesquita ◽

Margarida Freitas ◽

...

Keyword(s):

Real World ◽

Botulinum Neurotoxin ◽

Type A ◽

A Review of Tolerance and Safety Profiles of Long-Term Botulinum Neurotoxin Type A in Asian Patients with Hemifacial Spasm and Benign Essential Blepharospasm

Neuro-Ophthalmology ◽

10.1080/01658107.2021.1916043 ◽

2021 ◽

pp. 1-8

Author(s):

Kenneth K. A. Hei Lai ◽

Alan Tsang ◽

Andrew K. T. Kuk ◽

Callie K. L. Ko ◽

Edwin Chan ◽

...

Keyword(s):

Hemifacial Spasm ◽

Botulinum Neurotoxin ◽

Type A ◽

Asian Patients ◽

Essential Blepharospasm

21. Clinical differences between botulinum neurotoxin type A and B toxins

Toxicon ◽

10.1016/j.toxicon.2014.11.024 ◽

2015 ◽

Vol 93 ◽

pp. S8-S9 ◽

Cited By ~ 2

Author(s):

Anna Rita Bentivoglio

Keyword(s):

Botulinum Neurotoxin ◽

Type A ◽